Publications by authors named "A Eitan"
Article Synopsis
- The study aimed to assess changes in hemoglobin levels and kidney function in patients 5-12 months after undergoing transcatheter aortic valve replacement (TAVR), along with exploring the relationship between these changes.
- After TAVR, the average hemoglobin level significantly improved, with anemia in patients decreasing from 67.5% to 53.9%, even though there was a slight decline in kidney function.
- The analysis did not find specific clinical predictors for ongoing anemia post-TAVR, suggesting that TAVR may help reduce gastrointestinal blood loss associated with severe aortic stenosis (AS).
Introduction: Patients with ST-elevation myocardial infarction (STEMI) and late arrival (>12 h) after symptom onset, are at high risk for mortality and heart failure and represent a challenge for management. We aimed to define patient characteristics, management, and outcome of late-arrival STEMI in Israel over the last 20 years.
Methods: We analyzed data of late-arrival STEMI (12-48 h and > 48 h) from the biennial acute coronary syndrome Israeli Surveys (ACSIS), as well as time-dependent changes [early (2000-2010) Vs.
Background: Ethnic minorities may face disparities in access to health care and clinical outcomes. Transcatheter aortic valve replacement (TAVR) has an established role in treatment of patients with severe symptomatic aortic stenosis, however outcome of these procedures among different demographics within the multi-ethnic Israeli society is unknown. We sought to compare mortality following TAVR between Jewish and Arab patients in Israel.
View Article and Find Full Text PDF